Why the study?
What are the clinical manifestations and outcomes of fondaparinux-associated heparin-induced thrombocytopenia?
What are the clinical manifestations and outcomes of fondaparinux-associated heparin-induced thrombocytopenia?
Although fondaparinux is often recommended for HIT management, it carries a rare but real risk of inducing HIT itself, necessitating cautious use.
Authors
No takes yet. Share an insight, caveat, or question.
Requires vigilance for HIT with fondaparinux; extends case-level data on adrenal hemorrhage and poor outcomes.
Bhatt et al. (2013) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: